Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 1

Interventions

pembrolizumab 16 Radiotherapy 15 Drug Therapy 14 Paclitaxel 13 Cisplatin 12 Carboplatin 10 Immunotherapy 9 Esophagectomy 9 Radiation 8 Fluorouracil 8 Surgical Procedures, Operative 7 Capecitabine 7 Blood Specimen Collection 7 Oxaliplatin 6 Nivolumab 6 Immune Checkpoint Inhibitors 6 Chemoradiotherapy 6 nimotuzumab 5 Trastuzumab 5 130-nm albumin-bound paclitaxel 5 sintilimab 4 camrelizumab 4 Leucovorin 4 trastuzumab deruxtecan 3 tislelizumab 3 patritumab deruxtecan 3 Surveys and Questionnaires 3 Endoscopy 3 Bevacizumab 3 toripalimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Esophageal Neoplasms × Fatty Acids, Omega-3 × Clear all

NCT07272382 2025-12-09

ESO-Shanghai28

Fudan University

Phase NA Recruiting

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡